Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
No clinical trials
Always consult a qualified healthcare provider before starting, stopping, or changing any treatment plan
Retatrutide is not currently licensed in the UK and is only accessible through approved clinical trials, as no EAMS designation has been granted by the MHRA
How PlexusDx Supports a More Personalized Approach Genetic predispositions in GLP-1 receptor signaling, GIPR pathways, and metabolic genes (such as FTO and MC4R variants) may provide context for why some patients experience better appetite suppression or weight loss with specific GLP-1 formulations
Double-check your dose calculation before your next injection to prevent a repeat
Most are mild and improve within the first few weeks of treatment
US$ 28.63
US$ 26.72
US$ 23.34
US$ 26.82
US$ 22.37
